These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12633529)
21. Cost-effectiveness study comparing imatinib with interferon-alpha for patients with newly diagnosed chronic-phase (CP) chronic myeloid leukemia (CML) from the Chinese public health-care system perspective (CPHSP). Chen Z; Wang C; Xu X; Feng W Value Health; 2009; 12 Suppl 3():S85-8. PubMed ID: 20586990 [TBL] [Abstract][Full Text] [Related]
22. Generics in chronic myeloid leukemia: current arguments for and against and the established evidence. Soysal T; Eskazan AE; Ar MC Expert Rev Hematol; 2014 Dec; 7(6):697-9. PubMed ID: 25292262 [TBL] [Abstract][Full Text] [Related]
27. Imatinib mesylate in the treatment of chronic myeloid leukaemia. Druker BJ Expert Opin Pharmacother; 2003 Jun; 4(6):963-71. PubMed ID: 12783592 [TBL] [Abstract][Full Text] [Related]
28. Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia? Kimura S; Kako S; Wada H; Sakamoto K; Ashizawa M; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Yamazaki R; Oshima K; Nishida J; Watanabe T; Kanda Y Leuk Res; 2011 Jan; 35(1):e11-2. PubMed ID: 20952061 [No Abstract] [Full Text] [Related]
29. Imatinib mesylate: a new pill for chronic myelogenous leukemia. Parmar KK; King RS Cancer Pract; 2001; 9(5):263-5. PubMed ID: 11879324 [No Abstract] [Full Text] [Related]
30. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib. Heartin E; Walkinshaw S; Clark RE Leuk Lymphoma; 2004 Jun; 45(6):1307-8. PubMed ID: 15360020 [No Abstract] [Full Text] [Related]
31. Chromosomal abnormalities in chronic myeloid leukemia: evidence of a hierarchy in imatinib treated cells. Ostro D; Cheung K; Kamel-Reid S; Lipton JH Leuk Lymphoma; 2007 May; 48(5):1029-31. PubMed ID: 17487749 [No Abstract] [Full Text] [Related]
32. Doctors condemn NICE's guidance on leukaemia drug. Mayor S BMJ; 2002 Jun; 324(7350):1352. PubMed ID: 12052793 [No Abstract] [Full Text] [Related]
33. Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma. Mughal TI; Goldman JM Eur J Cancer; 2001 Mar; 37(5):561-8. PubMed ID: 11290430 [No Abstract] [Full Text] [Related]
36. Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia. Murphy M; Close J; Lottenberg R; Rajasekhar A Am J Med Sci; 2014 Mar; 347(3):254-5. PubMed ID: 24553361 [No Abstract] [Full Text] [Related]
37. Decrease of resistance to imatinib in leukaemia. Bakalova R; Zhelev Z; Ohba H Lancet; 2002 May; 359(9319):1776-7. PubMed ID: 12049890 [No Abstract] [Full Text] [Related]
39. Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU. Conti RM; Padula WV; Larson RA Ann Hematol; 2015 Apr; 94 Suppl 2(0 2):S249-57. PubMed ID: 25814091 [TBL] [Abstract][Full Text] [Related]